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Abstract
Background: Angiotensin converting enzyme (ACE) gene contains a polymorphism, consisting of either the presence 
(I) or absence (D) of a 287 base pair fragment. Deletion (D) is associated with increased circulating ACE (cACE) activity. It 
has been suggested that the D-allele of ACE genotype is associated with power-oriented performance and that cACE 
activity is correlated with muscle strength. Respiratory muscle function may be similarly influenced. Respiratory muscle 
strength in infants can be assessed specifically by measurement of the maximum inspiratory pressure during crying 
(Pimax). Pressure-time index of the respiratory muscles (PTImus) is a non-invasive method, which assesses the load to 
capacity ratio of the respiratory muscles.
The objective of this study was to determine whether increased cACE activity in infants could be related to greater
respiratory muscle strength and to investigate the potential association of cACE with PTImus measurements as well as
the association of ACE genotypes with cACE activity and respiratory muscle strength in this population.
Methods: Serum ACE activity was assayed by using a UV-kinetic method. ACE genotyping was performed by 
polymerase chain reaction amplification, using DNA from peripheral blood. PTImus was calculated as (Pimean/Pimax) × 
(Ti/Ttot), where Pimean was the mean inspiratory pressure estimated from airway pressure, generated 100 milliseconds 
after an occlusion (P0.1), Pimax was the maximum inspiratory pressure and Ti/Ttot was the ratio of the inspiratory time to 
the total respiratory cycle time. Pimax was the largest pressure generated during brief airway occlusions performed at 
the end of a spontaneous crying effort.
Results: A hundred and ten infants were studied. Infants with D/D genotype had significantly higher serum ACE 
activity than infants with I/I or I/D genotypes. cACE activity was significantly related to Pimax and inversely related to 
PTImus. No association between ACE genotypes and Pdimax measurements was found.
Conclusions: These results suggest that a relation in cACE activity and respiratory muscle function may exist in infants. 
In addition, an association between ACE genotypes and cACE activity, but not respiratory muscle strength, was 
demonstrated.
Background
Angiotensin I-converting enzyme (ACE) is a zink metal-
lopeptidase whose main functions are to convert angio-
tensin I into vasoactive and aldosterone-stimulating
peptide angiotensin II and to degrade vasodilator kinins.
Circulating ACE (cACE) is found in biological fluids and
originates from endothelial cells. ACE is also an impor-
tant component of the local renin-angiotensin systems
(RASs), which have been identified in diverse tissues,
including lung and skeletal muscles [1,2]. A polymor-
phism of the human ACE gene has been identified in
humans and contains a polymorphism consisting of
either the presence (insertion, I) or absence (deletion, D)
of a 287 base pair (bp) fragment [3]. The deletion is asso-
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ciated with increased ACE activity in both tissue [4] and
circulation [5]. Circulating ACE activity was stable when
serially measured in the same individuals, while large dif-
ferences among subjects were observed [6]. The I/D poly-
morphism accounts for approximately half of the
observed variance in ACE levels [5]. However, the pres-
ence of quantitative trait loci controlling ACE levels was
suggested [7].
D - a l l e l e  o f  A C E  g e n o t y p e  h a s  b e e n  a s s o c i a t e d  w i t h
power-oriented performance, being found in excess in
short-distance swimmers [8] and with greater strength
gains in the quadriceps muscle [9]. Furthermore, it has
been suggested that cACE activity has been associated
directly with muscle strength in healthy Caucasians,
naïve to strength training [10]. Thus, respiratory muscle
function and specific respiratory muscle strength may be
similarly influenced.
Respiratory muscle strength in infants can be assessed
specifically by measurement of the maximum inspiratory
pressure during crying (Pimax) [11,12]. Pressure-time
index of the respiratory muscles (PTImus) is a non-inva-
sive method, which assess the load to capacity ratio of the
respiratory muscles [13]. PTImus has been validated in
both adults [14] and infants [15].
The aim of this study was to test the hypothesis that
increased cACE activity in infants could be related to
greater respiratory muscle strength assessed by measure-
ment of Pimax. We further investigated the potential asso-
ciation of cACE with PTImus measurements, as well as
the association of ACE genotypes with cACE activity and
respiratory muscle strength in this population.
Methods
Patients
Infants cared for at the Neonatal Intensive Care Unit-
Pediatric Department of the University General Hospital
of Patras, Greece, were eligible for the study. Infants were
entered into the study if parents gave informed written
consent. The study was approved by the local Research
Ethics Committee. The studied population was recruited
from a study examining the association of ACE genotypes
on respiratory muscle function in infants. All infants
were studied before discharge, in supine position, at least
one hour after a feed. Infants had no respiratory symp-
t om s  f or  a t  leas t  3 da ys  be f or e m eas ur e m en t. F urt h er -
m o r e ,  i n f a n t s  w e r e  o n  f u l l  o r a l  f e e d s ,  h a d  s e r u m
electrolytes, calcium, magnesium and phosphates within
normal range and did not receive any methylxanthines.
Blood sampling for circulating ACE activity determina-
tion was performed the previous or the same day of the
measurements.
ACE genotype determination
ACE genotyping was performed on DNA extracted from
0.5 ml of whole blood, collected from an indwelling cath-
eter or via peripheral venipuncture during routine blood
sampling. The blood samples were stored at -80°C in
EDTA vacutainer tubes. The method has been previously
described [16]. Briefly, DNA was extracted by using
Qiamp spin columns (Blood mini kit- Qiagen, QIAGEN
Inc., Germantown, U.S.A). DNA was analyzed by electro-
phoresis on an agarose gel. DNA amplification of the 16th
ACE intron was performed using two sets of primers
flanking the polymorphic site, (outer and inner primers),
as mistyping of the D/D genotype has been reported to
occur using conventional amplification with insertion/
deletion (I/D) flanking primer [17].
Plasma ACE activity determination
An additional 1 ml of whole blood was collected during
routine blood sampling. Serum was separated immedi-
ately from the whole blood by centrifugation at 1500 g for
10 min. The samples were stored at -20°C in vacutainer
tubes until analysis. Serum ACE activity was assayed by
using a UV-kinetic method (Medicon SA) and an AU480
Clinical Chemistry System (Beckman Coulter, Inc, High
Wycombe, UK). The determination of ACE was based on
the calculation of the rate of absorbance change at 340
nm during the hydrolysis of the substrate N-(3-(2-
(furyl)acryloyl)-L-phenylalanylglycylglycine (FAPGG) to
N-(3-(2-(furyl)acryloyl)-L-phenylalanine (FAP) and gly-
cylglycine. The method has a detection limit of 7 U/L, lin-
earity between 7-140 U/L of ACE and an intra-assay
coefficient of variation between 2.26% and 4.86%.
Measurement of respiratory muscle function
Airway flow was measured using a pneumotachograph
(Mercury F10L, GM Instruments, Kilwinning, Scotland)
connected to a differential pressure transducer (DP45,
range ± 2 cm H2O, Validyne Corp, Northridge, CA, USA).
Airway pressure (Paw) was measured from a side port on
the pneumotachograph, using a differential pressure
transducer (DP45, range ± 100 cm H2O, Validyne Corp,
Northridge, CA, USA). The signals from the differential
pressure transducers were amplified, using a carrier
amplifier (Validyne CD 280, Validyne Corp, Northridge,
CA, USA) and they were recorded and displayed in real
time on a computer (Dell Optiplex GX620, Dell Inc.,
T e x a s ,  U . S . A )  r u n n i n g  L a b v i e w ™  s o f t w a r e  ( N a t i o n a l
Instruments, Austin, Texas, U.S.A) with analog-to-digital
sampling at 100 Hz (16-bit NI PCI-6036E, National
Instruments, Austin, Texas, U.S.A).
Measurement of Pimax
To measure Pimax, a facemask (total deadspace, 4.5 mL)
was held firmly over the infant's nose and mouth. A small
needle leak in the mask was used in order to prevent glot-
tic closure and artificially high Pimax [13]. The airway was
occluded at the end of a spontaneous crying effort using a
unidirectional valve attached to the pneumotachograph,
which allowed expiration but not inspiration. The occlu-Dimitriou et al. Respiratory Research 2010, 11:57
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sion was maintained for at least four inspiratory efforts.
At least three sets of airway occlusions were performed
and the maximum Pimax  achieved for individual was
recorded.
Measurement of PTImus
P0.1 was calculated as the airway pressure generated 100
milliseconds after an occlusion, while the infant was qui-
etly breathing. At least four airway occlusions were per-
formed and average P0.1 was calculated. Pressure-time
index of the inspiratory muscles (PTImus), was calculated
as: PTImus = (Pimean/Pimax) × (Ti/Ttot) where Pimean was
the average airway pressure during inspiration, obtained
from the formula Pimean = 5 × P0.1 × Ti [18]. Pimax was the
maximum inspiratory airway pressure, Ti was the inspira-
tion time and Ttot was the total time for each breath, cal-
culated from the airway flow signal.
Muscle mass increases with maturity and body growth
[19] and Pimax continues to increase outside the neonatal
period [11]. Therefore, in order to examine the associa-
tion of ACE genotype with respiratory muscle strength,
Pimax was also related to body weigth at the time of mea-
surement.
Statistical analysis
Data was tested for normality using the Shapiro-Wilk and
D'Agostino skewness tests. Differences between ACE
genotype groups were assessed for statistical significance,
using the Kruskal-Wallis and Dunn's post-hoc non para-
m e t r i c  a n d  C r a m e r ' s  V  t e s t s ,  a s  a p p r o p r i a t e .  S i m p l e
regression analysis was performed to determine whether
cACE is related to Pimax  and PTImus measurements.
Stepwise multiple regression analysis was performed to
determine if cACE activity is related to respiratory mus-
cle strength, assessed by measurement of Pimax and PTI-
mus measurements, independently to weight at
measurement, ACE genotyping, postmenstrual age
(PMA), gender and support from mechanical ventilation.
Statistical analysis was performed using StatView 5.0
(SAS Institute, Inc., NC, USA) and NCSS 2007 (NCSS,
Utah, USA)
Table 1: Characteristics of the whole study population
Number of studied infants 110
Gestational age (weeks) 36 (27-40)
Birth weight (g) 2705 (960-4150)
Gender (male) 62 (56.4)
Preterm 75 (57.7)
Duration of mechanical ventilation (days) 0 (0-59)
Diagnoses on admission
Respiratory distress syndrome (RDS) 37 (33.6)
Transient tachypnea of the newborn (TTN) 17 (15.5)
Meconium aspiration syndrome 5 (4.5)
Infection 16 (14.5)
Congenital pneumonia 6 (5.5)
Prematurity (gestational age ≤ 34 weeks and 
birthweight < 2 kg without additional 
problems on admission)
15 (13.7)
Birth depression 6 (5.5)
Intrauterine growth retardation 5 (4.5)
Airleaks 2 (1.8)
Meconium plug 1 (0.9)
At the time of measurement
Postnatal age (days) 9 (1-107)
Postmenstrual age (PMA) (weeks) 37.1 (32.4-46.7)
Preterm (PMA<37 weeks) 57 (43.8)
Weight (g) 2633 (1850-4050)
cACE activity (U/L) 42.5 (16.7-89.0)
Pimax (cmH2O) 65.0 (36.9-91.8)
Pimax/weight (cmH2O/kg) 24.5 (14.5-47.1)
PTImus 0.062 (0.023-0.149)
Data are demonstrated as n (%) or median (range).
Abberviations: cACE: circulating ACE; Pimax: maximum inspiratory 
pressure during crying; PTImus: pressure-time index of the 
respiratory muscles
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Sample size
Interim analysis of the data of 50 infants demonstrated a
correlation of magnitude r = 0.23 between Pimax and cACE
activity approaching statistical significance. Recruitment of
106 subjects would allow us to detect a correlation of mag-
nitude r = 0.24 between Pimax and cACE levels with 80%
power at 5% significance level ("Alpha", the probability of
rejecting a true null hypothesis).
Results
Whole study population
Between February 2007 and September 2008 one hun-
dred ten infants were recruited. Fifty infants (45.5%)
required ventilation in the initial stage of their illness
with a median duration of ventilatory support of 3.3 days
(range 1.5-59). The characteristics of the study popula-
tion are presented in table 1.
Eighteen infants (16.4%) were homozygous for the I-
allele (I/I), 40 (36.4%) homozygous for the D-allele (D/D)
and 52 infants (47.2%) were heterozygous I/D. ACE geno-
type distribution was in Hardy-Weinberg equilibrium
(HWE), (Chi square for HWE 0.025, p = 0.874). Overall,
there were no significant differences in the characteristics
of the infants with I/I, D/D and I/D ACE genotypes (table
2). Neither Pimax measurements, nor Pimax adjusted for
weight at measurement, were statistically different
between the three groups, (table 2). Infants with D/D
genotype had higher serum ACE activity than infants
with I/I or I/D genotypes (Kruskal-Wallis, p = 0.028;
Dunn's test, z-value = 2.37, p < 0.05 and z-value = 2.12, p
< 0.05, respectively) (table 2), (figure 1). No difference, in
regards to serum ACE activity, was found between infants
with I/I and I/D genotypes (Dunn's test, z-value = 0.83,
n.s). Linear regression analysis demonstrated that cACE
activity was significantly related to Pimax after logarithmic
transformation (r = 0.253, t-value = 2.72, p = 0.0075) and
inversely related to PTImus (r = -0.238, t-value = -2.55, p
= 0.012). Furthermore, stepwise regression analysis
revealed that Pimax after logarithmic transformation was
significantly related to cACE activity (p = 0.0045) and
weight at measurement (p = 0.0081), independent of ACE
genotyping, PMA, gender and support from mechanical
ventilation (table 3). In addition, PTImus was related
(inversely) to cACE activity (p = 0.00037) and to ACE
genotypes (p = 0.00163), independent of weight at mea-
surement, PMA, gender and support from mechanical
ventilation (table 4).
Infants that never required ventilatory support
The characteristics of the infants that never required any
form of ventilatory support (n = 60) are presented in table
5. In this subgroup, 10 infants (16.6%) were homozygous
I/I, 25 (41.7%) homozygous D/D and 25 infants (41.7%)
were heterozygous I/D (table 6). ACE genotype distribu-
tion was in Hardy-Weinberg equilibrium (HWE), (Chi
square for HWE 0.741, p = 0.389).
Infants with I/I, D/D and I/D ACE genotypes, did not
differ in regards to their characteristics and in regards to
either Pimax measurements or Pimax adjusted for weight at
measurement (table 6). Linear regression analysis dem-
onstrated that cACE activity was significantly related to
Pimax after logarithmic transformation (r = 0.421, t-value
= 3.532, p = 0.0008) and inversely related to PTImus (r = -
0.289, t-value = -2.29, p = 0.025).
Discussion
In this study a positive correlation between serum ACE
activity and respiratory muscle strength, assessed by
Pimax measurement, and a negative correlation between
serum ACE activity and PTImus in infants, was demon-
strated. Infants homozygous for the D-allele had higher
cACE activity than infants homozygous for the I-allele
and heterozygous I/D . F urthermore, cACE activity was
related to Pimax and PTImus independent of other factors
which could affect respiratory muscle function. The cor-
relation between cACE activity and either Pimax or PTI-
mus was replicated on a subpopulation of the main
group, consisting of infants that never required any form
of respiratory support.
Mouth pressures generated during crying efforts, could
provide an index of respiratory muscle strength in awake
infants [13]. The test has been previously validated in
infants [11,12]. Pimax measurement is a volitional test of
respiratory muscle strength, however, the generated pres-
sures produced during crying, are considered to be maxi-
mal [19].
Fatigue of respiratory muscles may result in an inability
to maintain adequate alveolar ventilation and respiratory
failure. Diaphragmatic pressure-time index (PTIdi) is a
measure of the load-capacity ratio of the diaphragm. It
describes the pressure-generating capacity of the dia-
phragm, independent of respiratory frequency or the type
of load imposed on the respiratory system [13] and it is
closely related to the endurance time, referred to as the
point where the inspiratory muscles failed to maintain a
task despite maximal effort [20]. The determination of
PTIdi, however, is rather invasive, since it requires the
placement of an esophageal catheter. Assessment of
inspiratory muscle function by measurement of a non-
invasive pressure-time index of the respiratory muscles
(PTImus) was first described by Gaultier et al. [18]. In
spontaneously breathing infants, an agreement between
PTImus and PTIdi measurements using Bland and Alt-
man analysis, was found [15].
It has been suggested, based primarily on observational
evidence, that the D-allele of ACE polymorphism wasDimitriou et al. Respiratory Research 2010, 11:57
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associated with greater training-related strength gain and
power-oriented performance [21]. An excess of the ACE
D-allele has been found among elite sprint runners [22]
and swimmers [8]. In addition, ACE genotypes in adults,
were associated with strength response to muscle train-
ing and D-allele carriers experience greater strength
increase than II homozygotes [9,23]. ACE genotype, how-
ever, is not associated with baseline muscle strength and
size [24]. Furthermore, several studies have suggested
that I-allele has been associated with superior ex ercise
endurance, being found with increased frequency in elite
distance runners [22], rowers [25], triathletes [26] and
mountaineers [27]. A study in healthy Caucasian naïve to
strength training, suggested that cACE activity was sig-
nificantly associated with baseline muscle strength [10].
In the current study, ACE genotype was associated with
cACE activity, which is in accordance with present litera-
ture [4,5]. Infants with D/D ACE genotype had increased
cACE activity compared to infants either homozygous for
the I-allele or heterozygous I/D. Although serum ACE
activity was associated with increased respiratory muscle
strength, such association was not demonstrated in
regards to ACE genotypes. One explanation is that the
deletion accounts for approximately 47% of the intra-
individual variation in plasma ACE activity in Caucasians
[5]. Furthermore, cACE activity is a continuous variable
and would provide greater statistical power than a cate-
gorical variable such as ACE genotype. Similar results,
however, have been demonstrated by others, where an
association between ACE genotyping with pre-training
muscle strength was not found [9,28]. Nevertheless, the
correlation between Pimax and cACE activity is rather
weak, as approximately only 7% of the variation in Pimax
can be accounted for by the variation in cACE activity.
A maturational effect on Pimax  has been previously
demonstrated [12]. Several factors could affect Pimax,
such as gestational age, PMA, birthweight and weight at
measurement [12]. Muscle mass increases with maturity
and body growth [19] and Pimax continues to increase out-
side the neonatal period [11]. Furthermore, ACE levels in
infants have been reported to be higher than in adults
[29], other studies, however, did not show any significant
correlation of cACE activity with age [30]. In this study,
respiratory muscle assessment was performed at the time
of the blood collection, therefore, any maturational effect
on Pimax and variation on cACE activity was avoided.
However, to examine the association of ACE genotype
Table 2: Characteristics of infants in relation to ACE genotypes
p value
ACE genotypes (n) II (18) ID (52) DD (40)
Gestational age (weeks) 36 (27-40) 35 (28-40) 36(29-40) 0.680a
Birth weight (g) 2780 (960-4150) 2705 (1065-3650) 2755 (1170-3820) 0.756a
Male gender 9 (50.0%) 28 (53.8%) 25 (62.5%) 0.097b
Duration of mechanical 
ventilation (days)
0 (0-59) 2 (0-21) 0 (0-8) 0.167a
At the time of measurement
Postnatal age (days) 8.5 (1-107) 9.5 (1-62) 8 (1-54) 0.686a
Weight (kg) 2660 (1850-4050) 2620 (1850-3680) 2657 (1880-3540) 0.618a
cACE activity (U/L) 39.3 (24.3-72.3) 41.1 (16.7-71.9) 51.1 (23.9-89.0) 0.028a
Pimax (cmH2O) 71.3 (49.3-88.7) 61.1 (36.9-90.8) 66.1 (42.4-91.8) 0.09a
Pimax/weight (cmH2O/kg) 25.3 (17.0-37.6) 23.5 (14.5-42.3) 24.5 (14.9-47.1) 0.267a
Data are demonstrated as n (%) or median (range).
aKruskal-Wallis testbCramer's V testDimitriou et al. Respiratory Research 2010, 11:57
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with respiratory muscle strength, Pimax was also related to
body weigth at the time of measurement.
The primary aim of this study was to examine the asso-
ciation of cACE activity with respiratory muscle strength
in infants. Secondary aims were to investigate the poten-
tial association of cACE with PTImus measurements and
ACE genotypes with cACE activity and respiratory mus-
cle strength in this population. An association between
ACE genotypes and PTImus in infants has been previ-
ously shown [31]. Thus, this issue was not examined in
this study. However, ACE genotype was included in the
stepwise regression analysis, as it is now known that it is
strongly correlated with PTImus.
The association of cACE activity and respiratory mus-
cle strength may be mediated through synthesis of angio-
tensin II (Ang II). Ang II could possibly act as a growth
factor in cardiac muscle [32] and its effect may be medi-
ated through Ang II type 1 (AT1) receptor [32]. Further-
more, Ang II may be necessary for optimal overload-
induced skeletal muscle hypertrophy, acting at least in
part via an AT(1) receptor-dependent pathway [33]. The
physiological properties of a motor unit correlate with
the histochemical properties of the constituent muscle
fibres [34]. ACE D-allele compared to I-allele is associ-
ated with an increased percentage of fast-twitch type IIb
skeletal muscle fibres [35], which produce greater force
per unit of cross-sectional area [36]. Ang II may be also
important in the redirection of blood flow from type I,
fatigue-resistant, to type II, fast-twitch, muscle fibres
[37]. Furthermore, in animal studies, Ang II infused into
Table 3: Results of stepwise regression analysis of factors related to Pimax measurements
Partial Correlation Coefficient t Value Significance
Dependent variable: Pimax
cACE activity 0.262 2.899 0.0045
Weight at measurement 0.244 2.697 0.0081
ACE genotypes 0.317 0.752
Postmenstrual age 0.283 0.778
Gender 0.077 0.939
Duration of mechanicalventilation 1.451 0.150
Table 4: Results of stepwise regression analysis of factors related to PTImus measurements
Partial Correlation Coefficient t Value Significance
Dependent variable: PTImus
cACE activity -0.339 -3.675 0.00037
ACE genotypes 0.298 3.233 0.00163
Weight at measurement 1.944 0.055
Postmenstrual age 0.792 0.430
Gender 1.364 0.169
Duration of mechanical ventilation 0.490 0.625Dimitriou et al. Respiratory Research 2010, 11:57
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rat hindlimps increases the tension during tetanic stimu-
lation [37]. Other actions of Ang II, that might explain the
association between cACE activity and respiratory mus-
cle strength, include the increased noradrenaline release
from peripheral sympathetic nerve terminals and the
CNS, facilitating sympathetic transmission [38,39]. Cir-
culating ACE may also influence diaphragmatic muscle
strength, through the degradation of kinins. In animal
studies, bradykinin reduces the phenylephrine-induced
hypertrophy of cardiomyocytes [40]. Thus, elevated
cACE may influence muscle strength via this pathway.
Several factors may affect respiratory muscle function,
such as nutrition [41], prolonged ventilatory support [42],
drugs [43-45], as well as phosphate [46], calcium [47] and
magnesium [48] blood levels. In addition, hypoxia [49]
and hypercapnia [50] reduce diaphragmatic contractility
in young piglets. All infants were measured prior to dis-
charge, being free of any respiratory symptoms and on
full enteral feeds, they did not receive any medication and
their biochemistry blood tests were within the normal
range during measurements.
This study has potentially important implications,
given the availability of ACE inhibitors. A recent study
has demonstrated that in patients with chronic heart fail-
ure, long-term therapy with ACE inhibitors improved
respiratory muscle strength [51]. However, it was an
uncontrolled observational study with a very small sam-
ple size. Maximum inspiratory pressure measurement is a
volitional test, therefore, in order to assess respiratory
muscle strength in subjects with chronic heart failure
under therapy, other factors that would interfere with
respiratory muscle function, should be taken into
a c c o u n t .  S o m e  s t u d i e s  h a v e  d e m o n s t r a t e d  t h a t  A C E
inhibitor treatment improves exercise capacity [52,53]
and decrease long term decline in physical function in
elderly adults [54]. However, all studies were observa-
tional and referred to either disable, hypertensive sub-
jects or adults with congestive heart failure.
Conclusions
These results suggest that a relation in cACE activity and
respiratory muscle function, as assessed by measurement
of Pimax and PTImus, may exist in infants. No association
between ACE genotypes and Pimax measurements was
found. In addition, an association of D-allele of ACE gen-
otype with increased cACE activity in infants was dem-
onstrated. Circulating ACE accounts for only a small
proportion of the total body RAS, therefore, ACE activity
in muscles may be a more important factor in regards to
respiratory muscle properties. Further work is required
Figure 1 Comparison of cACE activity results in relation with ACE 
genotypes. Comparison of cACE activity results of infants with I/I (n = 
18), I/D (n = 52) and D/D (n = 40) ACE genotypes. Box and whisker plot: 
fine horizontal lines represent 10th, 25th, 50th, 75th and 90th centiles of 
cACE. Outliers are plotted as discrete data points.
Table 5: Characteristics of infants that never required 
respiratory support
Number of studied infants 60
Gestational age (weeks) 37 (30-40)
Birth weight (g) 2845 (1260-3820)
Gender (male) 36 (60.0)
Preterm 28 (46.7)
At the time of measurement
Postnatal age (days) 6.5 (1-31)
Postmenstrual age (PMA) (weeks) 37.6 (32.7-41.4)
Preterm (PMA<37 weeks) 22 (36.7)
Weight (g) 2765 (1880-3680)
cACE activity (U/L) 44.3 (16.7-89.0)
Pimax (cmH2O) 64.3 (36.9-91.8)
Pimax/weight (cmH2O/kg) 23.9 (14.5-47.1)
PTImus 0.061 (0.028-0.117)
Data are demonstrated as n (%) or median (range).Dimitriou et al. Respiratory Research 2010, 11:57
http://respiratory-research.com/content/11/1/57
Page 8 of 9
to clarify the effect of ACE inhibitor treatment on respi-
ratory muscle function.
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